Approach for Colon Cancer Therapy Using Apc Peptides

Boman, Bruce M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Exploratory/Developmental Grants (R21)
• Project #: 3R21CA071531-01S1
• Application #: 2542955
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1996-09-16
• Project End: 1998-08-31
• Budget Start: 1996-09-16
• Budget End: 1997-08-31
• Support Year: 1
• Fiscal Year: 1997

Institution

• Name: CA*TX, Inc.
• DUNS #: 086618183
• City: Ann Arbor
• State: NE
• Country: United States

Publications

Boman, B M; Fields, J Z; Bonham-Carter, O et al. (2001) Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res 61:8408-11

Gao, Z; Gao, Z; Fields, J Z et al. (1999) Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug-resistant colon-adenocarcinoma cells. Int J Cancer 82:346-52

Gao, Z; Gao, Z; Fields, J Z et al. (1998) Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells. Anticancer Res 18:3073-6

Hughes-Fulford, M; Boman, B (1997) Growth regulation of Gardner's syndrome colorectal cancer cells by NSAIDs. Adv Exp Med Biol 407:433-41